Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiologyheart failure, electrophysiologyhypertension, structural heart disease, use of pharmaceuticals, and COVID-19.   

American College of Cardiology (ACC) President Christopher Kramer, MD, FACC, spoke at a hearing of the U.S. House Appropriations Subcommittee on Labor, Health and Human Services, Education, and Related Agencies March 9 to urge lawmakers to allocate full funding for the Cardiomyopathy Health Education, Awareness, Research, and Training in Schools (HEARTS) Act (H.R.6829). It was signed into law in the closing weeks of the Biden administration. #ACC

ACC testifies in Washington to get funding for the HEARTS Act amid big cuts to healthcare

ACC President Christopher Kramer, MD, testified before a Congressional subcommittee to ask for federal funding to support a new law aimed at reducing sudden cardiac arrest deaths, and to support NIH research.

OSU researchers studying ability of silver nanoparticles to enhance medical imaging

Why researchers believe silver nanoparticles could 'revolutionize' medical imaging

Researchers at Oregon State University are working on developing a way to make contrast agents more targeted. 

Michael Reardon, MD, explained the low-risk Evolut 5-year results of TAVR vs. SAVR at ACC 2025. #ACC #ACC25 #ACC2025

5-year Evolut Low Risk Data: Durable clinical outcomes, outstanding valve performance

Sponsored by Medtronic

The late-breaking five-year results of the Evolut Low-Risk Trial presented at ACC.25 showed positive results for the Evolut TAVR system when compared to SAVR.

FDA clears new device for enabling access to the heart’s surface without an exposed needle

CardioVia's ViaOne technology includes a blunt-tip needle that remains concealed to help interventional cardiologists and electrophysiologists treat cardiac arrhythmias with a reduced risk of perforation or any other complications. 

Richard Kovacs, MD, MACC, chief medical officer, American College of Cardiology (ACC), former ACC president, and professor of clinical medicine, Indiana University School of Medicine, explains the most important late-breaking cardiology pharmacology trials at the ACC 2025 meeting. #ACC25 #ACC2025

Late-breaking cardiovascular drug trials took center stage at ACC.25

Richard Kovacs, MD, detailed some the most important late-breaking cardiology pharmacology trials presented at ACC.25.

Thumbnail

Deaths after TAVR are on the rise: Is the pandemic to blame or should cardiologists be concerned?

COVID-19 may help explain the increased rates of cardiac and noncardiac mortality among TAVR patients, but there are several other factors to consider as well. Researchers explored nearly 11 years of STS/ACC registry data to learn more.

U.S. Department of Health and Human Services (HHS) sign.

Judge halts HHS’s $11B cuts to state healthcare programs

In issuing an injunction, a federal district court in Rhode Island ruled that states and their populations would suffer irreparable harm if the funds allocated by Congress were not granted to them.

Venus-PowerX TAVR valve developed by Venus MedTech

Cardiologists perform world’s first TAVR procedures with new fully retrievable valve

Researchers detailed their experience performing the very first TAVR procedures with the Venus-PowerX TAVR valve from Venus MedTech. The valve includes a wire-controlled mechanism that makes it possible to recapture after full deployment.